Cure Parkinson's Quarterly Research Grant 2026 for Researchers (Funding up to $500,000)
Applications are now open for the Quarterly Research Grant Funding Programme by Cure Parkinson’s, offering substantial funding for innovative research aimed at transforming the future of Parkinson’s disease treatment. With grants ranging from $100,000 to $500,000, this opportunity supports scientists, institutions, and companies working to slow, stop, or even reverse the progression of the disease.
This program prioritizes translational research, focusing on projects that can progress toward human trials within five years. It is open to international applicants, encouraging collaboration across sectors to tackle complex health challenges like Parkinson’s disease.
Eligibility
Open to international applicants, including academic institutions, research organizations, and commercial entities. Researchers from low- and middle-income regions, including parts of Africa, are particularly encouraged to apply.
Benefits
Funding between $100,000 and $500,000 depending on project scope, with preclinical research funding up to £250,000 GBP. Support for clinical trials and related sub-studies is also provided.
